Charles Explorer logo
🇬🇧

Adherence to Aclasta(R) (SPC): results of a non-interventional clinical trial

Publication at Faculty of Medicine in Hradec Králové |
2014

Abstract

This was a 24-month, multicentre, non-interventional study designed to study physicians adherence to SPC in patients with osteoporosis indicated to zoledronic acid (Aclasta) treatment. Primary assessment was to consider the percentage of patients who underwent standard procedures, e.g. creatinine and calcium measurement, adequate hydration and antiphlogistics administration.

The results show a satisfactory compliance with instructions specified in SPC.